Multiple strategies with the synergistic approach for addressing colorectal cancer

Area of Science:

• Oncology and Nanomedicine
• Cancer Therapeutics
• Drug Resistance Mechanisms

Background:

• P-glycoprotein efflux pumps are a primary cause of chemotherapeutic failure in cancer treatment.
• Multidrug resistance (MDR) and angiogenesis are critical challenges in effective colorectal cancer (CRC) therapy.
• Cancer cells utilize metabolic pathways, such as fatty acid metabolism, for survival and proliferation.

Purpose of the Study:

• To review strategies employing nanoformulations of 5-Fluorouracil and curcumin for CRC treatment.
• To explore targeting P-glycoprotein-mediated multidrug resistance and angiogenesis in CRC.
• To investigate the potential of utilizing cancer cell energy sources for targeted therapy.

Main Methods:

• Review of literature on nanoformulations incorporating 5-Fluorouracil and curcumin for CRC.
• Analysis of strategies to overcome P-glycoprotein efflux and enhance chemosensitivity.
• Exploration of targeting fatty acid metabolism in colorectal cancer cells.

Main Results:

• Nanoformulations of 5-Fluorouracil and curcumin demonstrate potential in overcoming MDR and enhancing therapeutic efficacy.
• Curcumin acts as a chemosensitizer and chemotherapeutic agent, improving 5-Fluorouracil activity.
• Targeting fatty acid metabolism presents a novel approach for selective cancer cell elimination.

Conclusions:

• Combined nanoformulations of 5-Fluorouracil and curcumin offer a promising strategy for overcoming MDR in CRC.
• Exploiting cancer cell-specific metabolic vulnerabilities, like fatty acid utilization, can lead to targeted therapies.
• Multi-pathway targeting approaches enhance treatment efficacy and overcome resistance in colorectal cancer treatment.